Orthofix Medical INC Form 4 insider transactions

Patrick Fisher, President of Global Orthopedics at Orthofix Medical Inc., sold 1,996 shares of common stock to cover tax obligations related to the settlement of restricted stock units.

Engine Capital Management, a 10% owner and director, has acquired an additional 1,250 shares of Orthofix Medical Inc. common stock for $11.105 per share.

Orthofix Medical Inc. Director Michael Finegan was granted 26,087 deferred stock units, increasing his beneficial ownership to 57,391 shares.

Orthofix Medical Inc. Director Michael E. Paolucci was granted 18,841 deferred stock units, increasing his beneficial ownership to 86,948 shares.

Orthofix Medical Inc. Director Vickie L. Capps has been granted 18,841 deferred stock units, aligning her interests with shareholders through future equity vesting.

Orthofix Medical Inc. Director Wayne Burris was granted 18,841 deferred stock units, vesting in June 2026, increasing his total beneficial ownership to 50,539 shares.

Orthofix Medical Inc. Director Alan Lee Bazaar was granted 18,841 deferred stock units, vesting on June 18, 2025, increasing his total beneficial ownership to 49,824 shares.

Orthofix Medical Inc. Director Charles R. Kummeth received an award of 18,841 deferred stock units, increasing his total beneficial ownership to 59,237 shares.

Orthofix Medical Inc. Director Jason Hannon was granted 18,841 deferred stock units, increasing his total beneficial ownership to 70,594 shares.

Orthofix Medical Inc. Director Shweta Maniar received an award of 18,841 deferred stock units, vesting over one year, as part of her compensation.

Orthofix Medical Inc. Director John B. Henneman III was granted 18,841 deferred stock units, increasing his beneficial ownership to 83,706 shares.

Aviva McPherron, President of Global Operations & Quality at Orthofix Medical Inc., sold 3,728 shares of common stock for tax withholding purposes related to restricted stock unit settlement.

Orthofix Medical Inc. President, Global Spine, Max Reinhardt, sold 1,643 shares of common stock on June 11, 2025, to cover tax withholding obligations related to restricted stock unit settlement.

Orthofix Medical Inc. Director Alan Lee Bazaar has increased his beneficial ownership in the company by purchasing 2,250 shares of common stock at $10.92 per share.

Engine Capital and related entities report increased holdings in Orthofix Medical Inc. common stock through open market purchases.

Orthofix Medical Inc.'s CEO, Massimo Calafiore, recently purchased 10,000 shares of the company's common stock at an average price of $12.54 per share.

Director Alan Bazaar recently purchased additional shares of Orthofix Medical Inc., increasing his direct holdings in the company.

Engine Capital and related entities report acquiring additional shares of Orthofix Medical Inc. at $12.31 per share, increasing their beneficial ownership.

Jorge Andres Cedron, Chief Legal Officer of Orthofix Medical Inc., sold 3,816 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Geoffrey C. Gillespie, CAO of Orthofix Medical Inc., sold 76 shares of common stock on April 2, 2025, to satisfy tax withholding obligations related to the settlement of restricted stock units.

Lucas Vitale, CP&BOO of Orthofix Medical Inc., sold 4,287 shares of common stock on March 18, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.

Geoffrey C. Gillespie, CAO of Orthofix Medical Inc., sold 296 shares of common stock on March 18, 2025, to satisfy tax withholding obligations related to the settlement of restricted stock units.

Director Vickie L. Capps reports acquisition of deferred stock units and stock options in Orthofix Medical Inc.

Orthofix Medical Inc.'s CEO, Massimo Calafiore, purchased 9,914 shares of common stock at an average price of $17.43 on March 5, 2025.

Lucas Vitale, CP&BO of Orthofix Medical Inc., reports acquiring shares and stock options, increasing his beneficial ownership in the company.

CFO Julie Andrews reports acquisition of stock options and restricted stock units in Orthofix Medical Inc.

Max Reinhardt, President of Global Spine at Orthofix Medical Inc., reports acquiring and disposing of common stock and employee stock options.

Geoffrey C. Gillespie, CAO of Orthofix Medical Inc., reports the acquisition and disposal of common stock and stock options, with a transaction date of March 3, 2025.

Patrick Fisher, President of Global Orthopedics at Orthofix Medical Inc., reports acquisition of shares and options, along with disposal of shares, in a recent transaction.

Jorge Andres Cedron, CLO of Orthofix Medical Inc., reports acquiring and disposing of common stock and stock options on March 3, 2025.